Patents by Inventor William E. Sanders
William E. Sanders has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11559688Abstract: A method of treating a patient having a blood pressure comprises delivering neuromodulation therapy to sustain or increase the blood pressure. The neuromodulation therapy includes placing a sympathetic therapy electrode in a posterior portion of a blood vessel and stimulating at least one extravascular cardiac sympathetic nerve fiber using said electrode.Type: GrantFiled: August 8, 2019Date of Patent: January 24, 2023Assignee: NuXcel2, LLCInventors: Stephen C. Masson, Terrance Ransbury, Richard S Stack, William E Sanders
-
Patent number: 10857352Abstract: A neuromodulation system includes a first therapy element adapted for positioning within a superior vena cava, and a second therapy element adapted for positioning within a pulmonary artery. The first therapy element is carried on a first elongate flexible shaft, and the second therapy element is carried on a second elongate flexible shaft. One of the first and second shafts is slidably received within a lumen of the other of the first and second shafts—so that the second therapy element may be advanced within the body relative to the first therapy element. A stimulator is configured to energize the first therapy element within the first blood vessel to deliver therapy to a first nerve fiber disposed external to the superior vena cava and to energize the second therapy element within the pulmonary artery to deliver sympathetic therapy to a second nerve fiber disposed external to the pulmonary artery.Type: GrantFiled: December 27, 2017Date of Patent: December 8, 2020Assignee: NUXCEL LimitedInventors: Terrance J Ransbury, Richard S Stack, William E Sanders, Stephen C Masson
-
Publication number: 20200206512Abstract: A method of treating a patient having a blood pressure comprises delivering neuromodulation therapy to sustain or increase the blood pressure. The neuromodulation therapy includes placing a sympathetic therapy electrode in a posterior portion of a blood vessel and stimulating at least one extravascular cardiac sympathetic nerve fiber using said electrode.Type: ApplicationFiled: August 8, 2019Publication date: July 2, 2020Applicant: Interventional Autonomics CorporationInventors: Stephen C. Masson, Terrance Ransbury, Richard S. Stack, William E. Sanders
-
Publication number: 20180117305Abstract: A neuromodulation system includes a first therapy element adapted for positioning within a superior vena cava, and a second therapy element adapted for positioning within a pulmonary artery. The first therapy element is carried on a first elongate flexible shaft, and the second therapy element is carried on a second elongate flexible shaft. One of the first and second shafts is slidably received within a lumen of the other of the first and second shafts—so that the second therapy element may be advanced within the body relative to the first therapy element. A stimulator is configured to energize the first therapy element within the first blood vessel to deliver therapy to a first nerve fiber disposed external to the superior vena cava and to energize the second therapy element within the pulmonary artery to deliver sympathetic therapy to a second nerve fiber disposed external to the pulmonary artery.Type: ApplicationFiled: December 27, 2017Publication date: May 3, 2018Applicant: Interventional Autonomics CorporationInventors: Terrance J. Ransbury, Richard S. Stack, William E. Sanders, Stephen C. Masson
-
Patent number: 9884182Abstract: A neuromodulation system includes a first therapy element adapted for positioning within a superior vena cava, and a second therapy element adapted for positioning within a pulmonary artery. The first therapy element is carried on a first elongate flexible shaft, and the second therapy element is carried on a second elongate flexible shaft. One of the first and second shafts is slidably received within a lumen of the other of the first and second shafts—so that the second therapy element may be advanced within the body relative to the first therapy element. A stimulator is configured to energize the first therapy element within the first blood vessel to deliver therapy to a first nerve fiber disposed external to the superior vena cava and to energize the second therapy element within the pulmonary artery to deliver sympathetic therapy to a second nerve fiber disposed external to the pulmonary artery.Type: GrantFiled: January 9, 2014Date of Patent: February 6, 2018Assignee: INTERVENTIONAL AUTONOMICS CORPORATIONInventors: Terrance J Ransbury, Richard S Stack, William E Sanders, Stephen C Masson
-
Publication number: 20170065818Abstract: A neuromodulation system for treating acute heart failure syndromes includes a first catheter having a parasympathetic therapy element adapted for positioning within a first blood vessel such as a superior vena cava, and a second catheter sympathetic therapy element adapted for positioning with a second, different, blood vessel such as the pulmonary artery. The catheters comprise a system in which one of catheters is slidably disposed over the other of the catheters. The system may further be slidably disposed over a third elongate element such as a Swan-Ganz catheter positionable within a pulmonary artery, such that the Swan-Ganz may be used for monitoring parameters such as blood pressure and cardiac output during neuromodulation therapy.Type: ApplicationFiled: September 8, 2015Publication date: March 9, 2017Inventors: Terrance J. Ransbury, William E. Sanders, Richard S. Stack, Colleen Stack
-
Publication number: 20160354607Abstract: A method of treating a patient having a blood pressure comprises delivering neuromodulation therapy to sustain or increase the blood pressure. The neuromodulation therapy includes placing a sympathetic therapy electrode in a posterior portion of a blood vessel and stimulating at least one extravascular cardiac sympathetic nerve fiber using said electrode.Type: ApplicationFiled: August 16, 2016Publication date: December 8, 2016Applicant: Interventional Autonomics CorporationInventors: Stephen C. Masson, Terrance Ransbury, Richard S. Stack, William E. Sanders
-
Patent number: 9446240Abstract: A method of treating autonomic imbalance in a patient includes energizing a first therapeutic element disposed to deliver therapy to a parasympathetic nerve fiber (e.g. vagus nerve), and energizing a second therapeutic element to deliver therapy to a sympathetic cardiac nerve fiber. At least one of the therapeutic elements is disposed in the vasculature superior to the heart. The therapy decreases the patient's heart rate and elevates or maintains the blood pressure of the patient.Type: GrantFiled: October 17, 2014Date of Patent: September 20, 2016Assignee: INTERVENTIONAL AUTONOMICS CORPORATIONInventors: Stephen C Masson, Terrance Ransbury, Richard S Stack, William E Sanders
-
Patent number: 9126048Abstract: A neuromodulation system for treating acute heart failure syndromes includes a first catheter having a parasympathetic therapy element adapted for positioning within a first blood vessel such as a superior vena cava, and a second catheter sympathetic therapy element adapted for positioning with a second, different, blood vessel such as the pulmonary artery. The catheters comprise a system in which one of catheters is slidably disposed over the other of the catheters. The system may further be slidably disposed over a third elongate element such as a Swan-Ganz catheter positionable within a pulmonary artery, such that the Swan-Ganz may be used for monitoring parameters such as blood pressure and cardiac output during neuromodulation therapy.Type: GrantFiled: October 28, 2013Date of Patent: September 8, 2015Assignee: INTERVENTIONAL AUTONOMICS CORPORATIONInventors: Terrance J Ransbury, William E Sanders, Richard S Stack, Colleen Stack
-
Patent number: 9067071Abstract: A method of treating autonomic imbalance in a patient includes energizing a first therapeutic element disposed in a superior vena cava of the patient to deliver therapy to a parasympathetic nerve fiber (e.g. vagus nerve), and energizing a second therapeutic element disposed within the superior vena cava to deliver therapy to a sympathetic cardiac nerve fiber. A neuromodulation system includes a parasympathetic therapy element adapted for positioning within a blood vessel, a sympathetic therapy element adapted for positioning within the blood vessel; and a stimulator to energize the parasympathetic therapy element to deliver parasympathetic therapy to a parasympathetic nerve fiber disposed external to the blood vessel and energize the sympathetic therapy element within the blood vessel to deliver sympathetic therapy to a sympathetic nerve fiber disposed external to the blood vessel. The therapy decreases the patient's heart rate and elevates or maintains the blood pressure of the patient.Type: GrantFiled: July 11, 2012Date of Patent: June 30, 2015Assignee: Interventional Autonomics CorporationInventors: William E. Sanders, Stephen C. Masson, Terrance Ransbury, Richard S. Stack
-
Publication number: 20150039058Abstract: A method of treating autonomic imbalance in a patient includes energizing a first therapeutic element disposed to deliver therapy to a parasympathetic nerve fiber (e.g. vagus nerve), and energizing a second therapeutic element to deliver therapy to a sympathetic cardiac nerve fiber. At least one of the therapeutic elements is disposed in the vasculature superior to the heart. The therapy decreases the patient's heart rate and elevates or maintains the blood pressure of the patient.Type: ApplicationFiled: October 17, 2014Publication date: February 5, 2015Inventors: Stephen C. Masson, Terrance Ransbury, Richard S. Stack, William E. Sanders
-
Publication number: 20140128750Abstract: A neuromodulation system includes a first therapy element adapted for positioning within a superior vena cava, and a second therapy element adapted for positioning within a pulmonary artery. The first therapy element is carried on a first elongate flexible shaft, and the second therapy element is carried on a second elongate flexible shaft. One of the first and second shafts is slidably received within a lumen of the other of the first and second shafts—so that the second therapy element may be advanced within the body relative to the first therapy element. A stimulator is configured to energize the first therapy element within the first blood vessel to deliver therapy to a first nerve fiber disposed external to the superior vena cava and to energize the second therapy element within the pulmonary artery to deliver sympathetic therapy to a second nerve fiber disposed external to the pulmonary artery.Type: ApplicationFiled: January 9, 2014Publication date: May 8, 2014Applicant: Interventional Autonomics CorporationInventors: Terrance J Ransbury, Richard S Stack, William E Sanders, Stephen C Masson
-
Publication number: 20140052208Abstract: A neuromodulation system for treating acute heart failure syndromes includes a first catheter having a parasympathetic therapy element adapted for positioning within a first blood vessel such as a superior vena cava, and a second catheter sympathetic therapy element adapted for positioning with a second, different, blood vessel such as the pulmonary artery. The catheters comprise a system in which one of catheters is slidably disposed over the other of the catheters. The system may further be slidably disposed over a third elongate element such as a Swan-Ganz catheter positionable within a pulmonary artery, such that the Swan-Ganz may be used for monitoring parameters such as blood pressure and cardiac output during neuromodulation therapy.Type: ApplicationFiled: October 28, 2013Publication date: February 20, 2014Applicant: Synecor LLCInventors: Terrance J Ransbury, William E Sanders, Richard S Stack, Colleen Stack
-
Publication number: 20130072997Abstract: A method of treating autonomic imbalance in a patient includes energizing a first therapeutic element disposed in a superior vena cava of the patient to deliver therapy to a parasympathetic nerve fiber (e.g. vagus nerve), and energizing a second therapeutic element disposed within the superior vena cava to deliver therapy to a sympathetic cardiac nerve fiber. A neuromodulation system includes a parasympathetic therapy element adapted for positioning within a blood vessel, a sympathetic therapy element adapted for positioning within the blood vessel; and a stimulator to energize the parasympathetic therapy element to deliver parasympathetic therapy to a parasympathetic nerve fiber disposed external to the blood vessel and energize the sympathetic therapy element within the blood vessel to deliver sympathetic therapy to a sympathetic nerve fiber disposed external to the blood vessel. The therapy decreases the patient's heart rate and elevates or maintains the blood pressure of the patient.Type: ApplicationFiled: July 11, 2012Publication date: March 21, 2013Inventors: William E. Sanders, Stephen C. Masson, Terrance Ransbury, Richard S. Stack
-
Publication number: 20130072995Abstract: A neuromodulation system includes a first therapy element adapted for positioning within a superior vena cava, and a second therapy element adapted for positioning within a pulmonary artery. Each therapy element is carried on a corresponding elongate flexible shaft. One of the shafts is slidably received within a lumen of the other so that the second therapy element may be advanced within the body relative to the first. A stimulator energizes the first therapy element within the first blood vessel to deliver therapy to a first nerve fiber disposed external to the superior vena cava and to energize the second therapy element within the pulmonary artery to deliver sympathetic therapy to a second nerve fiber disposed external to the pulmonary artery. For treatment of heart failure, the first nerve fiber may be a vagus nerve and the second nerve fiber may be a sympathetic nerve fiber.Type: ApplicationFiled: July 11, 2012Publication date: March 21, 2013Inventors: Terrance Ransbury, Richard S. Stack, William E. Sanders, Stephen C. Masson
-
Patent number: 4813758Abstract: A vehicle parking guide for use on a supporting surface disposed in a preselected travel path. The vehicle parking guide includes a plate adapted to be fixedly mounted on the supporting surface. It also includes lateral vehicle positioning members for ensuring proper lateral vehicle positioning to coincide with the preselected travel path as the vehicle approaches the supporting surface. It further includes a longitudinal vehicle positioning member for ensuring proper longitudinal vehicle positioning to coincide with a preselected stopping point as the vehicle is stopped near the supporting surface. The vehicle parking guide is also provided with at least one fastener capable of fixedly mounting the plate on the supporting surface. With these features, the vehicle parking guide is adapted for properly positioning a vehicle in a preselected position as it is parked.Type: GrantFiled: April 27, 1987Date of Patent: March 21, 1989Inventor: William E. Sanders